NLB Life Sciences’ Post

Benchmark your MedTech GenAI strategy – hear how companies are adopting genAI in medtech with Rohit Alimchandani, Head of Life Sciences UK&I, Cognizant. Watch the full panel discussion for free here: https://bit.ly/3W2iJgD Learn how gen AI is disrupting the industry and how best to prepare for it, with experts on the panel from Novartis, Novo Nordisk and Smith+Nephew. #MedTech #GenAI #Innovation #MedTechAI

If you missed it, you can still watch this webinar on demand, featuring Cognizant's Rohit Alimchandani discussing the adoption of genAI in #medtech.

We are ready to kick off the American Medical Device Summit and look forward to great learning and interaction over the next 2 days. Happiest Minds has a great breadth of experience delivering value to multi-billion dollar MedTech companies as well as startups focused on medical device development. Moreover, AI is poised to be a gamechanger and carries tremendous upside to positively disrupt MedTech innovation. If you are attending the American Medical Device Summit, please stop by our booth (#48) and meet with Srinivas Iyengar, Sundar Ramaswamy and Amit Kumar to know more. #AMDsummit #medtech #AIpotential #ai #happiestminds

No surprises for guessing where this weeks Industry Insights starts... As well as another push for tomorrow's Inside MedTech, we have loads of incredibly exciting funding stories, major acquisition announcements and some innovation that could make a difference to so many. Links to all articles in the comments. Keep on making a difference! #medtech #insidemedtech #medtechnews #medtechinvestment

🚀 Calling All Life Science Innovators! 🧬 Are you ready to take your groundbreaking research out of the lab and into the market? MedTech’s Research-to-Market Academic Program is here to help! Over the course of 3 weeks, this dynamic program equips scientists, engineers, and inventors with the tools to discover customers and commercialize their inventions. What’s included? 🔹 Virtual workshops & webinars 🔹 Industry expert connections 🔹 30 virtual interviews in your target market 🔹 Customized support for diagnostics, digital health, medical devices, therapeutics & more Learn More > medtech.gatech.edu Ready to transform your innovation into a market success? Let’s go! 🌟 #MedTech #ResearchToMarket #Innovation #LifeSciences #Entrepreneurship

Advances in science, medicine, and technology are transforming life sciences and medtech industries — creating tremendous opportunities for incumbents and new entrants alike. But these opportunities also pose a disruptive threat to existing business models. We partner with industry leaders to not only enhance immediate performance but also to innovate and implement transformative strategies that ensure long-term success. Discover how our expertise can empower your organization to make sense of discontinuous change, seize new growth opportunities, improve R&D effectiveness, and reinvent your commercial approach. Dive into our insights and discover how we're helping shape the future of life sciences and medtech at the link below. #lifesciences #medtech #innovation #transformation

Tech-Transfer in MedTech industry is coming! The consolidation of the partnership between Pariter Partners and imec.istart, finalized to scale deep-tech innovation at the European level, has led to an acceleration of joint scale-up programs. Pariter and imec.istart will jointly support selected teams active in #MedTech industry, with the goal of transferring technology and teams from the lab to the market. The support will include a dedicated and specific program for teams and research groups, active in #MedTech areas such as: AI in pre-operative planning, ICT technologies to improve prevention, innovative solutions for diagnosis, monitoring, treatment and cure of diseases, non-invasive tests used on biological samples, and many more. We strongly believe that focusing on teams within research centers that support #MedTech Technology Transfer, is a key factor to leverage R&D investments of the recent and future years. Ann Van Mele, Sven De Cleyn, Erik Vervloet, Valentina Franchini, Marta Provera, Tommaso Pravettoni #pariter #imecistart #medtech #innovation #techtransfer

🔍 𝗠𝗲𝗱𝗧𝗲𝗰𝗵 𝗮𝘀 𝗮𝗻 𝗜𝗻𝘃𝗲𝘀𝘁𝗺𝗲𝗻𝘁 𝗖𝗮𝘀𝗲: 𝗔 𝗦𝘂𝗰𝗰𝗲𝘀𝘀 𝗦𝘁𝗼𝗿𝘆 We’re excited to share the latest addition to our blog series, "MedTech as an Investment Case: A Success Story," written by Daniel Shoukier, 𝗲𝗻𝘁𝗿𝗲𝗽𝗿𝗲𝗻𝗲𝘂𝗿 𝗮𝗻𝗱 𝗺𝗲𝗱𝗶𝗰𝗮𝗹 𝗱𝗲𝘃𝗶𝗰𝗲 𝗲𝘅𝗽𝗲𝗿𝘁. In this insightful post, Daniel reflects on his 15 years of experience in MedTech, offering a deep dive into both the challenges and success stories in the field. 𝗪𝗵𝗮𝘁 𝘄𝗲 𝗰𝗼𝘃𝗲𝗿: - Why 9 out of 10 medical device startups fail despite innovative products. - Key success factors for MedTech investments, including market demand, clinical benefits, and reimbursement strategies. - The robust growth potential of MedTech sectors like diagnostics, cardiovascular devices, and surgical tech. - Real-world examples of successful exits, such as Auris Health and Covidien. - MedTech remains a complex yet rewarding sector for angel investors, but with the right strategy and long-term outlook, the opportunities are significant. 👉 𝗥𝗲𝗮𝗱 𝘁𝗵𝗲 𝗳𝘂𝗹𝗹 𝗯𝗹𝗼𝗴 𝗽𝗼𝘀𝘁 𝗯𝗲𝗹𝗼𝘄 𝘁𝗼 𝗲𝘅𝗽𝗹𝗼𝗿𝗲 𝘁𝗵𝗲 𝗳𝘂𝗹𝗹 𝘀𝘁𝗼𝗿𝘆!

During Q1 of 2024, we added and updated over 150 company profiles in our Companies & Deals Database, and we're already well underway to exceed this quarterly milestone in Q2. Our Companies & Deals Database is your go-to resource for the latest market intel on early- and growth-stage Medtech companies. Designed to be comprehensive and high-quality, this tool is an invaluable asset for anyone needing detailed and up-to-date information on Medtech companies. With this database, our analysts become an immediate extension of your team. You’ll get online access to all of our startup intel including: • Comprehensive Profiles: Access detailed insights on 6,000 Medtech companies and their deals. • Exclusive Content: Dive into 3,430 CEO pitches, executive summaries, and insights exclusively from LSI events. All LSI USA ‘24 video content is now live on the platform! • Updated Regularly: We’re monitoring the latest fundraising deals and M&A activity at all times. Preview of Recently Covered Companies: • VizualEyes - Ergonomic microscopy solutions utilizing AI and other digital capabilities. • bluesail+ surgical - Minimally invasive surgical instruments • Allez Health - Biosensor platform for chronic conditions based on the continuous analysis of glucose • Kelvin Health - Non-invasive thermal imaging for the detection of vascular conditions To learn more about our Companies & Deals Database visit our website today: https://lnkd.in/gy6Pt6bg

AI and Biotech are Capturing Attention as Venture Capital (VC) Investments Hit Record High #aiindrugdiscovery Artificial intelligence (AI) and biotechnology are converging to revolutionize healthcare, leading to significant advancements in drug discovery, diagnostics, and personalized medicine. This synergy is attracting substantial investments and reshaping the landscape of medical rese ... Read More ▶️ https://buff.ly/3UYZDIe 💡#aiandbiotech #MedPulseAI #AIinHealthcare #AIinMedicine